悦康药业 (688658)
Youcare Pharmaceutical Group Co., Ltd.
K-Line Chart
No K-line data available
Company NameYuekang Pharmaceutical Group Co., Ltd.
Listing Date2020-12-24
Issue Price24.36RMB
Registered Capital4500010k RMB
Legal RepresentativeYu Weishi
Registered AddressNo. 6 Hongda Middle Road, Beijing Economic-Technological Development Area, Beijing
IndustryChemical Pharmaceuticals
Main BusinessR&D and production of high-end chemical drugs
Company ProfileYuekang Pharmaceutical Group is currently one of China's Top 100 Pharmaceutical Industrial Enterprises, a Top 10 Pharmaceutical R&D Enterprise, a National Technology Innovation Demonstration Enterprise, a National "Quality Benchmark" Enterprise, a "Green Factory" under the National Green Manufacturing System Construction Demonstration Project, a National Intelligent Manufacturing Pilot Demonstration Enterprise, and a National Certified Enterprise Technology Center. It is also a G20 industry leader under Beijing's Biopharmaceutical Industry Leapfrog Development Project, a Beijing Intelligent Manufacturing Benchmark Enterprise, and has been awarded the title of "Capital Civilized Unit". Guided by clinical needs, Yuekang Group continuously improves drug quality standards and develops innovative drugs through technological innovation. The company has successively established the National-Local Joint Engineering Laboratory for Cephalosporin Drug Polymorphism Research, the Beijing Engineering Research Center for Cardiovascular and Cerebrovascular Diseases, and the Pellet Sustained-Release and Controlled-Release Formulation Technology Development Platform. It has also set up the Yuekang Group Academician Expert Workstation and a Postdoctoral Research Station, winning the National Science and Technology Progress Second Prize in both 2015 and 2016. The Group currently has over 200 product specifications, covering multiple therapeutic areas including cardiovascular and cerebrovascular, digestive, antiviral, antitumor, and antibiotics.
Stock Details
1. Key Indicators
- Total Shares(W): 45000.00
- Circulating A-Shares(W): 45000.00
- Earnings Per Share(RMB): -0.3300
- Net Assets Per Share(RMB): 7.6214
- Operating Revenue(W RMB): 175910.61
- Total Profit(W RMB): -16481.13
- **Net Profit Attributable to Parent(W RMB) **: -14797.80
- Net Profit Growth Rate(%): -170.56
- Weighted Return on Equity(%): -4.2200
- Operating Cash Flow Per Share(RMB): 0.3740
- Undistributed Profit Per Share(RMB): 0.5368
- Capital Reserve Per Share(RMB): 5.8782
2. Main Business
The main business covers:
- Research, development, production, and sales of high-end chemical drugs
- Full industry chain including drug research and development, manufacturing, distribution, and sales
3. Company Basic Information
- Company Name: Youcare Pharmaceutical Group Co., Ltd.
- Listing Date: 2020-12-24
- Industry: Pharmaceutical Manufacturing
- Address: No. 6 Hongda Middle Road, Beijing Economic-Technological Development Area, Beijing
- Website: https://www.youcareyk.com/
- Company Profile: In April 2019, Youcare Limited convened a shareholders' meeting and passed a resolution to establish Youcare Pharmaceutical Group Co., Ltd. as a joint stock company with 26 shareholders of Youcare Limited as the co-founders. The establishment was based on the net assets audited by Ruihua Certified Public Accountants (Special General Partnership) as of July 31, 2018, which were converted into 360 million shares of the joint stock company, with the remaining balance recorded as capital reserve. In March 2020, Rongcheng Certified Public Accountants reviewed the capital contribution for this overall transformation and issued the "Capital Verification Report" (Rongcheng Yan Zi [2020] 230Z0038). In May 2019, the aforementioned 26 founders signed the "Sponsor Agreement" and convened the founding meeting on the same day, approving the plan to establish the joint stock company through overall transformation. They reviewed and passed the company's articles of association, as well as resolutions regarding the rules of procedure for the shareholders' meeting, board of directors, and board of supervisors, and elected the first board of directors and board of supervisors of Youcare Co., Ltd. In May 2019, Youcare Co., Ltd. obtained the renewed business license from the Beijing Administration for Industry and Commerce Economic-Technological Development Area Branch.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Fuyang Jingyue Yongshun Information Consulting Co., Ltd. | General Legal Person | 15374.01 | 34.16 |
| 2 | Heze Sanrong Equity Investment Partnership (Limited Partnership) | General Legal Person | 1440.00 | 3.20 |
| 3 | Heze Fengsheng Equity Investment Partnership (Limited Partnership) | General Legal Person | 1278.00 | 2.84 |
| 4 | Heze Jinran Equity Investment Partnership (Limited Partnership) | General Legal Person | 1278.00 | 2.84 |
| 5 | Fullgoal Precision Medical Flexible Allocation Mixed Securities Investment Fund - Class A | Fund | 1077.41 | 2.39 |
| 6 | E Fund Health Care Industry Mixed Securities Investment Fund - Class A | Fund | 976.65 | 2.17 |
| 7 | Heze Hewang Equity Investment Partnership (Limited Partnership) | General Legal Person | 720.00 | 1.60 |
| 8 | Fullgoal Pharmaceutical Innovation Equity Securities Investment Fund - Class A | Fund | 683.22 | 1.52 |
| 9 | Fullgoal Tianbo Innovation Theme Mixed Securities Investment Fund | Fund | 632.26 | 1.41 |
| 10 | China Merchants Pharmaceutical Health Industry Equity Securities Investment Fund | Fund | 311.97 | 0.69 |
5. Concept Sectors
- Immunotherapy
- Artificial Intelligence
- Generic Drugs
- Helicobacter Pylori
- Innovative Drugs
- AI Healthcare
- Margin Trading & Securities Lending
- Equity Transfer
- Break Issue Price
- STAR Market Biotech
- STAR 200
- SSE 580
Remarks
- Data update date: 2025-09-30
- Data source: Public Market Information